Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study
Authors:
Open Access
- 4 November 2011
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 13 (6) , R183
Abstract
Introduction: Studies have shown that fetal progenitor cells persist in maternal blood or bone marrow for more than 30 years after delivery. Increased trafficking of fetal cells occurs during pregnancy complications, such as hypertension, preeclampsia, miscarriage and intra-uterine growth restriction (IUGR). Women with these pregnancy complications are significantly more often HLA-class II compatible with their spouses. Women who later develop scleroderma also give birth to an HLA-class II child more often. From these prior studies we hypothesized that preeclampsia and other pregnancy complications could be associated with increased levels of fetal cell trafficking, and later be involved in the development of scleroderma. Methods: This study was a retrospective multi-centre matched case-control study. One-hundred-and-three women with systemic sclerosis (SSc) and 103 women with no history of SSc or other autoimmune disease were given a questionnaire regarding complications during pregnancy, such as hypertension, intra-uterine growth restriction (IUGR) and miscarriage. Conditional logistic regression analysis was used to assess associations. Results: We found a statistically significantly increased incidence of having had a pregnancy history of hypertension or a fetus with IUGR in women who subsequently developed SSc compared to healthy controls. We found an odds ratio of 2.6 (95% confidence interval (CI): 1.1 to 4.6) for hypertensive complications during pregnancy and an odds ratio of 3.9 (95% CI: 1.2 to 12.3) for intra-uterine growth restriction for women with SSc compared to healthy controls. Conclusions: This is the first study to show an association between hypertensive complications during pregnancy or IUGR and the development of SSc at a later age. We speculate that the pregnancy abnormalities may have resulted in increased fetomaternal trafficking, which may have played a role in the increased incidence of SSc. Further studies are indicated to examine this putative relationship.Keywords
This publication has 17 references indexed in Scilit:
- Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancyBest Practice & Research Clinical Obstetrics & Gynaecology, 2011
- ORIGINAL ARTICLE: Studies on the Compatibility of HLA‐Class II Alleles in Patient Couples with Severe Pre‐Eclampsia Using PCR–RFLP MethodsAmerican Journal of Reproductive Immunology, 2008
- Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2004
- The influence of fetal loss on the presence of fetal cell microchimerism: A systematic reviewArthritis & Rheumatism, 2003
- THE LEVELS OF CIRCULATORY FETAL DNA IN MATERNAL PLASMA ARE ELEVATED PRIOR TO THE ONSET OF PREECLAMPSIAHypertension in Pregnancy, 2002
- Disturbed Feto-Maternal Cell Traffic in PreeclampsiaObstetrics & Gynecology, 1998
- Microchimerism and HLA-compatible relationships of pregnancy in sclerodermaThe Lancet, 1998
- Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosisImmunogenetics, 1997
- Maternal–fetal immunology and autoimmune disease. Is some autoimmune disease auto‐alloimmune or allo‐autoimmune?Arthritis & Rheumatism, 1996
- Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.Proceedings of the National Academy of Sciences, 1996